BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4380046)

  • 21. On the role of rate of brain norepinephrine release in the antibenzoquinolizine action of desipramine.
    Sulser F; Soroko F
    Psychopharmacologia; 1965 Sep; 8(3):191-200. PubMed ID: 5885875
    [No Abstract]   [Full Text] [Related]  

  • 22. The regulation of norepinephrine synthesis in sympathetic nerves: effect of nerve stimulation, cocaine, and catecholamine-releasing agents.
    Alousi A; Weiner N
    Proc Natl Acad Sci U S A; 1966 Nov; 56(5):1491-6. PubMed ID: 4382063
    [No Abstract]   [Full Text] [Related]  

  • 23. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 24. [Histochemical study of the effect of drugs on the uptake of alpha-methylnoradrenaline by noradrenaline and dopamine containing neurones in rats treated with reserpine].
    Lorez HP
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(3):241-60. PubMed ID: 5358460
    [No Abstract]   [Full Text] [Related]  

  • 25. Brain catecholamines and the reserpine-induced stimulation of the pituitary-adrenal system.
    Hirsch GH; Moore KE
    Neuroendocrinology; 1968; 3(6):398-405. PubMed ID: 4388076
    [No Abstract]   [Full Text] [Related]  

  • 26. Reserpine-resistant uptake of catecholamines in isolated tissues of the rat. A histochemical study.
    Hamberger B
    Acta Physiol Scand Suppl; 1967; 295():1-56. PubMed ID: 6057304
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of desipramine and reserpine on the in vivo beta-hydroxylation of alpha-methyl-m-tyramine and alpha-methyldopamine.
    Meisch JJ; Carlsson A; Waldeck B
    J Pharm Pharmacol; 1967 Jan; 19(1):63-5. PubMed ID: 4382181
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-induced release of 3H-norepinephrine and 3H-serotonin from brain slices.
    Ng KY; Chase TN; Kopin IJ
    Nature; 1970 Oct; 228(5270):468-9. PubMed ID: 5482502
    [No Abstract]   [Full Text] [Related]  

  • 31. Recovery of the amine uptake-storage mechanism in nerve granules after reserpine treatment: inhibition by axotomy.
    Andén NE; Lundborg P
    J Pharm Pharmacol; 1970 Mar; 22(3):233-5. PubMed ID: 4399497
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of reserpine upon the synthesis of norepinephrine in the isolated rabbit heart.
    Rutledge CO; Weiner N
    J Pharmacol Exp Ther; 1967 Aug; 157(2):290-302. PubMed ID: 6039821
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake.
    Shaskan EG; Snyder SH
    J Pharmacol Exp Ther; 1970 Nov; 175(2):404-18. PubMed ID: 5481708
    [No Abstract]   [Full Text] [Related]  

  • 34. Distribution and metabolism of norepinephrine after its administration into the cerebroventricular system of the cat.
    Carr LA; Moore KE
    Biochem Pharmacol; 1969 Aug; 18(8):1907-18. PubMed ID: 4390276
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of chronic administration of nicotine on the turnover and metabolism of noradrenaline in the rat brain.
    Bhagat B
    Psychopharmacologia; 1970; 18(4):325-32. PubMed ID: 4395287
    [No Abstract]   [Full Text] [Related]  

  • 36. Reversal of the reserpine-induced suppression of the conditioned avoidance response by L-dopa: correlation of behavioral and biochemical differences in two strains of mice.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Feb; 159(2):422-8. PubMed ID: 5638661
    [No Abstract]   [Full Text] [Related]  

  • 37. Blockade of norepinephrine uptake by N,N'-bis-(1-naphthylmethyl)-1,4-cyclohexane bis-(methylamine) dihydrochloride in rodents.
    Lippmann W
    Biochem Pharmacol; 1969 Oct; 18(10):2495-505. PubMed ID: 5403986
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of the uptake and storage of L-( 3 H)norepinephrine in the rat brain.
    Coyle JT; Axelrod J
    J Neurochem; 1971 Nov; 18(11):2061-75. PubMed ID: 5129345
    [No Abstract]   [Full Text] [Related]  

  • 39. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
    Neff NH; Costa E
    J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
    [No Abstract]   [Full Text] [Related]  

  • 40. The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase.
    Shore PA
    Pharmacol Rev; 1966 Mar; 18(1):561-8. PubMed ID: 4379288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.